Qlife hires Jakob Broberg Lind as Sales Director Clinical
With this role, Qlife is establishing the commercial organization to take the Egoo system to the market and pave the way for the company’s growth. Jakob will take up his position no later than September 1st.
Jakob has extensive experience from international sales and business development within MedTech and healthcare and brings an excellent record of results and achievements in complex and competitive business environments. He comes from the role of Nordic Sales Manager & Strategic Account Manager at Boston Scientific.
“Qlife has a very strong team with an excellent reputation for developing diagnostic devices and biochemistry, and we are on a mission to make blood testing easier, smarter and better for everyone. To establish a position in the clinical market for the paradigm shifting Egoo system, we need an experienced sales professional to shape the sales strategy towards the B2B audiences in the healthcare sector – and we are extremely happy to have recruited Jakob,” says Thomas Warthoe, CEO of Qlife.
“To bring the game-changing Egoo system to the market is a unique opportunity, and I am very excited to join Qlife’s journey. With Qlife's product portfolio, pipeline and recognized expertise, I know that we are equipped to lead the revolutionary and inevitable change in blood testing and analysis. Qlife’s mobile and decentral solutions will save resources for both the individual and the healthcare system,” Jakob Broberg Lind says.
Initially focusing on the Nordic countries, Sales Director Clinical Jakob Broberg Lind will be globally responsible for designing, planning and executing initiatives that drive awareness, lead generation and sales, as well as for developing service products and payment models. His responsibility covers the full product range, mainly towards the clinical segment, i.e. hospitals, healthcare facilities, clinics, and the pharmaceutical industry. He will be running direct sales processes, as well as establishing sales partnerships with e.g. distributors and licensees. Jakob will also be responsible for the coming year's expansion of the commercial organization, covering sales, logistics and customer service. Jakob has a given place in Qlife’s executive management team in which he will contribute to the overall business development in addition to developing the company's sales.
For more information please contact:
Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34
About Qlife
Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement.
Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se).
Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.